Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Insufficient S-adenosylhomocysteine hydrolase compromises the beneficial effect of diabetic BMSCs on diabetic cardiomyopathy

Fig. 3

SAH metabolism in normal and diabetic BMSCs. Diabetes BMSCs had a decreased expression of SAHH protein (a, b) compared with the nondiabetic BMSCs (n = 4). The increased metabolites SAH (c, nmol/mg) and Hcy (d, μmol/mg), especially SAH, in diabetes BMSCs also suggested an insufficient SAHH activity (n = 5). *P < 0.05 versus nondiabetic BMSCs group.

Back to article page